| Date | Title | Description |
| 15.10.2024 | Hologic to Buy Gynesonics | Hologic (Nasdaq: HOLX), a Marlborough, MA-based women’s health company, acquired Gynesonics, a Redwood City, CA-based medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $3... |
| 30.07.2024 | Flo Health Lands $200M As Women’s Health Funding Holds Strong | 2 Shares Email Facebook Twitter LinkedIn
London-based Flo Health, a provider of a popular women’s health app, announced Tuesday that it has raised more than $200 million in a Series C round backed by General Atlantic.
The financing sets a v... |
| 27.11.2023 | Gynesonics: Women’s Healthcare Company Secures $67 Million | Gynesonics – a women’s healthcare company focused on developing minimally invasive solutions for symptomatic uterine fibroids – recently announced that it has secured an incremental $42.5 million in financing (total of $67.2 million inclusi... |
| 03.11.2023 | Gynesonics Raises $67.2M Financing | Gynesonics, a Redwood City, CA-based healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, raised $42.5M in funding.
The round, which brought, since an initial investment in April 20... |
| 02.11.2023 | Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure | - |
| 02.11.2023 | Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure | - |
| 01.11.2023 | CORRECTION – Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure | - |
| 01.11.2023 | Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure | - |
| 11.04.2023 | Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization | - |
| 11.04.2023 | GYNESONICS NAMES INDUSTRY VETERAN SKIP BALDINO PRESIDENT AND CEO, ANNOUNCES $25M FINANCING TO EXPAND WORLDWIDE COMMERCIALIZATION | - |
| 28.02.2023 | Innovative New Procedure To Treat Symptomatic Uterine Fibroids Is Now Available In Cincinnati For The First Time | Innovative New Procedure To Treat Symptomatic Uterine Fibroids Is Now Available
Gynesonics’ Sonata Treatment provides patients with an incision-free outpatient option. Now offered at David B. Schwartz, MD
I am so pleased with the efficacy a... |
| 13.01.2021 | Gynesonics Receives $50M Senior Secured Term Loan | Gynesonics, a Redwood City, CA-based healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications, received... |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to Gynesonics | - |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to Gynesonics | WOODSIDE, Calif., Jan. 12, 2021 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior se... |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to Gynesonics | |
| 12.01.2021 | Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to VERO Biotech | WOODSIDE, Calif., Jan. 12, 2021 – Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secu... |
| 03.01.2019 | Gynesonics Completes $75M Equity Financing | Gynesonics, a Redwood City, Calif.–based women’s healthcare company, completed a $75m equity financing.
The round was led by Bain Capital Life Sciences with participation from existing investors Abingworth, Advanced Technology Ventures (ATV... |
| 03.01.2019 | Gynesonics Raises $75M |
REDWOOD CITY, CA, Gynesonics said today that it raised $75 million in equity financing led by Bain Capital Life Sciences.
>> Click here for more funding data on Gynesonics
>> To export Gynesonics funding data to PDF and Exce... |
| 22.07.2015 | Gynesonics gets $43M to back pivotal trial of uterine fibroid ablation device | - |
| 22.07.2015 | Gynesonics Raises $43M in Equity Financing | Gynesonics, a Redwood City, CA-based women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, raised $43m in equity financing.
The round was co-led by new investor Endeavour Vis... |
| 22.07.2015 | Daily funding roundup - July 22, 2015 | Events.com has now raised a total of $17M; Darktrace landed $22.5M; Kinetic Social closed $17.5M
Events.com has raised a new round of funding. The size of the round was undisclosed, but it was led by Arctaris and with participation from La ... |
| 24.04.2015 | Gynesonics raises $3m for VizAblate fibroid device | California’s Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.
The Redwood City-based company, which disclosed the April 9 offering in a recent regulatory fili... |
| 23.10.2014 | Gynesonics wins FDA nod for VizAblate pilot trial | Gynesonics said it won an FDA investigational device exemption for its VizAblate system with an outpatient option for treating symptomatic uterine fibroids.
The trial will investigate the safety and effectiveness of VizAblate in treating he... |
| 20.02.2013 | Gynesonics Completes $21M Series D |
REDWOOD CITY, CA, Healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced a Series D financing led by HBM Partners based in Switzerland.
>> Click here for more funding data on Gynesoni... |
| 20.02.2013 | Gynesonics Raises $21M Series D Funding | Gynesonics Inc., a Redwood City, California-based women’s healthcare company, raised a $21m Series D funding.
The round was led by HBM Partners, with participation new investor Correlation Ventures and existing investors Abingworth, Advance... |
| 25.01.2007 | Gynesonics, a device-maker for uterine fibroid tumors, raises $16.5M | Gynesonics, a Menlo Park company focused on making medical devices for women’s health, has raised $16.5 million in a second round of financing.
The company is developing a device to treat uterine fibroid tumors. The company’s statement is h... |
| 20.09.2006 | Gynesonics raises $2M in debt | Gynesonics, a Redwood City company that develops medical devices for women’s health, including minimally invasive treatments for uterine fibroid tumors, has raised $2 million in debt from Hercules Technology Growth Capital, Hercules said in... |
| - | Gynesonics | “Click Here Advancing technologies to improve women’s lives. Transcervical Fibroid Ablation for Treatment of Symptomatic Uterine Fibroids The world’s FIRST and ONLY intrauterine fibroid ablation system that combines the safety of ultrasound... |
